Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience

BACKGROUND: The aim of the study was to evaluate the achievement of ‘no evidence of disease activity’ (NEDA) over a 12-month period in a large multicenter population with relapsing remitting multiple sclerosis (RRMS) treated with delayed-release dimethyl fumarate (DMF) and teriflunomide (TRF) using...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ther Adv Neurol Disord
Glavni autori: D’Amico, Emanuele, Zanghì, Aurora, Callari, Graziella, Borriello, Giovanna, Gallo, Antonio, Graziano, Giusi, Valentino, Paola, Buccafusca, Maria, Cottone, Salvatore, Salemi, Giuseppe, Ragonese, Paolo, Bossio, Roberto Bruno, Docimo, Renato, Grimaldi, Luigi Maria Edoardo, Pozzilli, Carlo, Tedeschi, Gioacchino, Zappia, Mario, Patti, Francesco
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2018
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6131312/
https://ncbi.nlm.nih.gov/pubmed/30210582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286418796404
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items